This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Conclusion
To eliminate cancer differences in Latino populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient advocates, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing differences. In the process, most of the speakers made ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Using Science to Address Latino Health Inconsistencies in Research
Eliseo J. Pérez-Stable, M.D., is Director of the NIMHD at the National Institutes of Health (NIH). Health Differences and Non-Medical Drivers of Health Dr. Pérez-Stable began his presentation by discussing the ways in which science can reduce differences in healthcare. First, standardized surveys, tools, and measurements are needed so that data can be combined, facilitating discovery through large data sets. Science should also be an engine for promoting variety in ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Transformative Strategies in Science and Access in the US
Dr. Edith A. Perez is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic College of Medicine and the Chief Medical Officer at Bolt Biotherapeutics. Her presentation outlined strategies for health improvement as exemplified by important committees of the National Academies of Sciences, Engineering, and Medicine (NASEM) and Stand Up To Cancer (SU2C). The NASEM initiative, which was requested by congress, focuses on improving the reflectivity of people in ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Leading Pathways: The Hispanic/Latino Survivorship Study
Dr. Frank Penedo is Associate Director of Cancer Survivorship & Behavioral Translational Sciences at the Sylvester Comprehensive Cancer Center at the University of Miami. The Leading Pathways Study Dr. Penedo began by presenting a summary of Leading Pathways, a Hispanic/Latino survivorship study, a collaboration between the Mays Cancer Center at UT Health San Antonio and the Sylvester Comprehensive Cancer Center at the University of Miami. The study has five key aims, the ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Novel Therapeutic Approach to Reduce Health Challenges in B-cell Acute Lymphoblastic Leukemia in Hispanic/Latino Children
Dr. Sinisa Dovat is Professor of Pediatrics, Pharmacology, and Biochemistry and Molecular Biology at Pennsylvania State University College of Medicine. He is also Four Diamond Endowed Chair and Director of Translational Research and Experimental Therapeutics in Pediatric Hematology/Oncology at Penn State University. B-Cell Acute Lymphoblastic Leukemia and Latino Children B-Cell acute lymphoblastic leukemia (B-ALL) ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Cancer Screening in Puerto Rico Challenges and Opportunities to Address Health Differences
Dr. Guillermo Tortolero-Luna is Director of the Division of Cancer Control and Population Sciences Program at the University of Puerto Rico Comprehensive Cancer Center. Cancer Statistics in Puerto Rico Dr. Tortolero-Luna began by describing the cancer landscape in Puerto Rico. In 2012, malignant cancers became the cause of death with the highest age-adjusted mortality rate in the territory. The highest cancer sites among Puerto Rican men are ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Updates in Genomics of Breast Cancer among Latina Women
Dr. Elad Ziv is a Professor of Medicine at the University of California San Francisco (UCSF), with a research focus on human genetics of cancer susceptibility and hematological traits. Genomics Explained To set the stage for his presentation, Dr. Ziv explained genomics in a lay-friendly way, describing it as a long series of letters. A change of one letter in this series, from an A to a G for example, can lead to anything from a change in height to a disease susceptibility. Not ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
COVID-19 Past, Present and Future
Dr. Carlos Del Rio is Distinguished Professor of Medicine, Global Health, and Epidemiology. He is also Executive Associate Dean of Emory University School of Medicine, and President-Elect of the Infectious Disease Society of America (IDSA). The Continued Presence of COVID-19 Dr. Del Rio began by pointing out that the COVID-19 pandemic is not over, despite gains made over the past year. At the time of his presentation, there were still two million global cases diagnosed daily, and close to 10,000 ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Framing Latino Cancer Research and the Census Bureau Data That Enable It
Mr. Robert L. Santos is the Director of the US Census Bureau, the first Latino to serve in that position. Lessons from a Vibrant Career Director Santos began by sharing wisdom gleaned from 40 years of research, including two ways in which it is important to think differently about research problems. First, researchers tend to emulate the methods and thought processes that they have been taught, but these conventional approaches may become self-propagating, and ...
